- Home
- ALXO vs SOS Comparison
ALXO vs SOS Comparison
Compare ALXO & SOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALXO
- SOS
- Stock Information
- Founded
- ALXO 2015
- SOS 2004
- Country
- ALXO United States
- SOS China
- Employees
- ALXO N/A
- SOS N/A
- Industry
- ALXO Biotechnology: Pharmaceutical Preparations
- SOS Finance: Consumer Services
- Sector
- ALXO Health Care
- SOS Finance
- Exchange
- ALXO Nasdaq
- SOS Nasdaq
- Market Cap
- ALXO 24.0M
- SOS 19.3M
- IPO Year
- ALXO 2020
- SOS 2017
- Fundamental
- Price
- ALXO $0.41
- SOS $6.17
- Analyst Decision
- ALXO Strong Buy
- SOS
- Analyst Count
- ALXO 6
- SOS 0
- Target Price
- ALXO $3.30
- SOS N/A
- AVG Volume (30 Days)
- ALXO 613.7K
- SOS 9.9K
- Earning Date
- ALXO 08-07-2025
- SOS 05-15-2025
- Dividend Yield
- ALXO N/A
- SOS N/A
- EPS Growth
- ALXO N/A
- SOS N/A
- EPS
- ALXO N/A
- SOS N/A
- Revenue
- ALXO N/A
- SOS $231,424,000.00
- Revenue This Year
- ALXO N/A
- SOS N/A
- Revenue Next Year
- ALXO N/A
- SOS N/A
- P/E Ratio
- ALXO N/A
- SOS N/A
- Revenue Growth
- ALXO N/A
- SOS 150.42
- 52 Week Low
- ALXO $0.40
- SOS $4.04
- 52 Week High
- ALXO $8.78
- SOS $15.51
- Technical
- Relative Strength Index (RSI)
- ALXO 40.22
- SOS 44.27
- Support Level
- ALXO $0.45
- SOS $5.51
- Resistance Level
- ALXO $0.53
- SOS $5.90
- Average True Range (ATR)
- ALXO 0.05
- SOS 0.23
- MACD
- ALXO -0.01
- SOS -0.11
- Stochastic Oscillator
- ALXO 4.98
- SOS 12.12
About ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
About SOS SOS Limited
SOS Ltd is a multifaceted company that leverages the power of data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other services. The company has three reporting segments: Commodity trading, Cryptocurrency mining, and Others. Key revenue is generated from Commodity trading.